Accelerate Your Cell, Gene and Cancer Immunotherapies to Market - Best Rate Ends Friday

Save $400 with the code XB15188BLOG by Friday, July 31 | Register here.

IBC's Cell Therapy Bioprocessing & Commercialization is the most focused conference for cost-effective and efficient cell, gene and immunotherapy approaches that accelerate cell-based product development and production towards commercial success >> Download the full agenda.

Key Topics Include: 
• Applying Genome Editing and Other Disruptive Technologies
• Developing Scalable and Transferrable Manufacturing Processes
• Biopreservation, Cold Chain Management and Patient Delivery
• Developing Successful Business Models
• Fostering Partnerships and Outsourcing Strategies for R&D and Manufacturing
• Pricing, Reimbursement, and Adoption
• Negotiating the Regulatory Pathways to Approval

_______________________________________________________________

Save $400 with the code IMMUNO15BL by Friday, July 31 | Register here.

IBC's Immuno-Oncology is the industry's leading resource for diving into the current issues surrounding efficacy and response rates with first generation immunotherapies to propel the next wave of cancer immunotherapies >> Download the full agenda.

Key Topics Include: 
• Strategies for Combination Therapeutics
• Advances with Checkpoint Inhibitors
• Agnostic Antibody Agents
• Advances in Cancer Vaccines
• Advancing the Next Wave of Cancer Immunotherapies

Share this article with your social network, just click below to share now!

Share |

Create Your Own Pathway for an Answer to Cancer

As innovations and discoveries in cancer immunotherapies progress at lightning speed, it is critical to understand the successes and challenges with current immunotherapies to separate the hype from the real opportunities.

IBC's Immuno-Oncology event develops tactics for improving the efficacy and response rates with first generation immunotherapies and builds a strategy for utilizing combination therapies, t-cell therapies, and checkpoint inhibitors to propel the next wave of cancer immunotherapies.

Immuno-Oncology

Advancing the Next Generation of Cancer Immunotherapies

September 31-October 1, 2015

Hilton Alexandria Marks Center

Alexandria, Virginia

Download the Immuno-Oncology brochure now to create your pathway for an answer to cancer: http://bit.ly/1KB4Nkg

Register today and explore the latest advances in Immuno-Oncology to:

• Develop next generation immunotherapies by understanding recent advances made with CAR-T and T-Cell therapies, checkpoint inhibitors, cancer vaccines, and agnostic antibodies
• Create a successful combination therapy strategy by gaining insights from global leaders on effective combinations

Optimize the discovery and development of your promising immunotherapies by hearing best practices and lessons learned from the first wave of cancer immunotherapies.

We hope to see you this fall!

Register by June 19th and save up to $400: http://bit.ly/1KB4Nkg

Best,

The Immuno-Oncology Team

@ibcusa

Futurebiopharma.blogspot.com

Share this article with your social network, just click below to share now!

Share |

Accelerate Your Path from Concept to Product

Learn to how to apply the cost-effective and efficient strategies you need to advance your cell, gene and immunotherapies towards commercial success by attending IBC's Cell Therapy Bioprocessing & Commercialization meeting, held September 30 - October 2, 2015 in Alexandria, VA.

Secure your seat today to attend this year's meeting and learn alongside fellow developers and end-users as you collectively share ideas, solutions and lessons learned to:

• Accelerate your path from concept to product by applying insightful and relevant strategies from 80+ industry thought-leading speakers across 7 focused tracks >> Download the brochure 
• Stay at the forefront of innovation by evaluating new technologies and cutting-edge data in the exhibit and poster hall 
• Jump start collaborations and partnerships through networking luncheons, private exhibit hall tours, evening cocktail receptions, interactive panel discussions and more 

New! All registered attendees gain access to Attendee Connect, the networking tool to make connecting with new customers and partners easier than ever before.

"Cell and gene immunotherapies continue to develop at a rapid pace. IBC continues to grow with this promising field. I will be back in the future!" - Prentice Curry, VP of Quality & Operations, Kite Pharma

Share this article with your social network, just click below to share now!

Share |

Last Chance to Save Up To $550 off Immuno-Oncology

As research in cancer immunotherapies continues to rapidly evolve, it is critical to separate the real opportunities from the hype. There has been great progress with checkpoint inhibitors, CAR-T and T-Cell therapies, cancer vaccines, agnostic antibodies, and combination therapies.

IBC's Immuno-Oncology provides the critical insights and strategies you need to improve response rates, efficacy, and get closer to a cure!

Download the full agenda for complete session and speaker information here:

Immuno-Oncology

Advancing the Next Generation of Cancer Immunotherapies

September 30 – October 1, 2015

Hilton Alexandria Mark Center, Alexandria, VA

Visit the website for more details: http://bit.ly/1A4NPY2

Don't miss out on maximum savings for IBC's Immuno-Oncology!

Register by May 15 to Save up to $550 off the standard rates: http://bit.ly/1A4NPY2

Register today and explore the latest advances in Immuno-Oncology to:

-          Design next generation immunotherapies by understanding recent advances made with CAR-T and T-Cell therapies, checkpoint inhibitors, cancer vaccines, and agnostic antibodies

-          Develop a successful combination therapy strategy by gaining insights from global leaders on effective combinations

-          Improve the discovery and development of your promising immunotherapies by hearing best practices and lessons learned from the first wave of cancer immunotherapies

Best,

The Immuno-Oncology Team 2015

@ibcusa

facebook.com/ibclifesciences

www.ibclifesciences.com/ImmunoOncology

Share this article with your social network, just click below to share now!

Share |

Stay cool this summer with a 30% savings! Register by August 15 and save 30% off the standard rate!

Register now to get your cool savings off IIR’s 10^th Annual Bioassays and Bioanalytical Method Development event with a 30% discount off the standard rate!*

Register here to join us and mention code XP1969Cool to take advantage of this discount.

The Bioassays event will take place October 20-22, 2014 in Boston, MA. Visit the website for full details. Don’t forget this event is co-located with IIR’s 15^th Annual Immunogenicity for Biotherapeutics —learn more here.

Download the agenda here to see what’s on tap.

Have any questions? Email Mike Madarasz.

Don’t miss a thing. Sign up for our email updates

Follow us on Twitter

Join us on LinkedIn

Share this article with your social network, just click below to share now!

Share |